Subtitle: The commercial protocol passed off as ancient wisdom is put to the test on its only declared ground. And there, the "synergy" between light and pill doesn't exist: it's been measured, and it's negative.

The "fake ancestral" has been born. You know what I'm talking about: the half-baked protocol that some marketers trying to reposition themselves as a return to nature—a little sun, a little supplementation, all packaged as ancient wisdom. The problem isn't commercial: it's lexical. "Ancestral" with the capsule inside is an oxymoron, because the cholecalciferol capsule is a pure industrial product: sheep shearing, lanolin, saponification, solvents, chemical conversion into 7-dehydrocholesterol, ultraviolet irradiation in the factory. No step in this supply chain exists in nature—I've documented it for years on this blog: https://www.evolutamente.it/la-vitamina-de-veleno-per-topi-approfondimento-sul-colecalciferolo/ and https://www.evolutamente.it/la-vitamina-d-colecalciferolo-e-un-farmaco-e-non-un-integratore/

The engineer's question is simply this: is there an experiment that proves that half a sun and half a pill work together? Yesterday, the answer was "no, it doesn't exist." Today, we can say more: the study (the only one in the literature) cited in a very long and boring YouTube video supporting the "synergy" measured blood levels of the pill, not an added clinical benefit. And the study that actually tested the combination came back negative.

Every day these charlatans comment on my articles, laughing, even though I've never personally done anything to them. Today (yesterday I finally had the chance to do it), I'm having fun doing it myself, because it's so shocking. These people pretend to be experts in the "scientific method"... Yes, of course, TO BRING HOME!

PSORIASIS AS A TESTING GROUND

Why psoriasis? Because it's the only area where someone has attempted to cite a study instead of a topic. Excellent: the method of this blog is to open the issue and read it line by line. The issue opens.

First, however, the underlying anatomical data—which is a framework for interpretation, and should be labeled as such—is not a verdict of this study. Skin exposed to light is a self-regulating system: when the ultraviolet dose increases, it photodegrades the excess before it becomes a dose (the literature itself calls it "averting toxicity"), and simultaneously produces an entire family of photoproducts—lumisterol, tachysterol, and metabolites via CYP11A1—which I wrote about yesterday:

NOT ONLY THE EPIMERS, BUT ALSO THE PRECURSORS OF VITAMIN D HAVE A POWERFUL BIOLOGICAL ACTIVITY THAT THE PILL COMPLETELY BYPASSES

The capsule is the operational opposite: a fixed-dose hormone, without physiological restraint, which enters the bloodstream in one go. The compromise between these two levels doesn't exist in biology: half a sun and half a pill isn't a protocol, it's a tactic to avoid displeasing anyone and try to sell to everyone. Whoever sits in the middle doesn't have a thesis: they have a business plan. Stuff for last-minute gatekeepers!

THE STUDY THEY CITE, OPENED LINE BY LINE (THIS IS WHY I DO NOT ACCEPT LIVE SHOWS ON TOPICS THAT NEED TO BE SERIOUSLY EXAMINED).

The study is this: Ala-Houhala MJ, Karppinen T, Vähävihu K, et al. “Narrow-band ultraviolet B treatment boosts serum 25-hydroxyvitamin D in patients with psoriasis on oral vitamin D supplementation” . Acta Dermato-Venereologica 2014;94(2):146-151. PMID 23995795, DOI 10.2340/00015555-1685. Abstract verified on PubMed on 09/14/2026.

What it contains, in full and without shortcuts:

• 12 patients with psoriasis (one study VERY SMALL), on oral supplementation with cholecalciferol 20 µg per day (800 IU — the minimum dose on the label, not an aggressive protocol even for supporters of supplementation), subjected to a cycle of NB-UVB.
• Serum 25(OH)D at baseline: 74,14 ± 22,9 nmol/L.
• At the 9th exposure: +13,2 nmol/L (95% CI 7,2–18,4). At the 18th: +49,4 nmol/L (95% CI 35,9–64,6).
• PASI, the Psoriasis Severity Index: from 8,7 ± 3,5 to 4,5 2,0 ± (p <0,001).

The conclusion, verbatim: “NB-UVB treatment significantly increases serum 25(OH)D in patients with psoriasis who are taking oral vitamin D supplementation, and the concentrations remain far from the toxic level .” Translation: NB-UVB significantly increases serum 25(OH)D in patients taking oral vitamin D, and the concentrations remain far from the toxic level.

Now the demolition, which is in the study's plan, not in my opinion.

First, it's a single-arm study. Twelve patients, no control group. No "UVB only" versus "UVB plus pill." From this design, not even a millimeter of healed skin can be attributed to the capsule—that's not a judgment: it's experimental arithmetic.

Second: Read the title. The verb "boosts" is right there, in the opening: "boosts serum 25-hydroxyvitamin D." The enhancement measured by the study is that of the BLOOD LEVELS of the pill's marker. The lamp enhances the pill in the blood; it's not the pill that enhances the lamp on the skin.

Third, PASI improvement is the standard effect of NB-UVB. Narrowband phototherapy has been a well-documented treatment for psoriasis for decades: the joint guidelines of the American Academy of Dermatology and the National Psoriasis Foundation recommend it as a Level A monotherapy for plaque psoriasis in adults (Elmets CA et al., J Am Acad Dermatol 2019;81(3):775-804, PMID 31351884). A PASI drop from 8,7 to 4,5 is exactly what this tool does on its own, every time. Attributing the improvement to the pill is like attributing the speed of the car to the second passenger.

A fine detail, noteworthy because it's in the study: at the start of treatment, the lesions showed low expression of vitamin D-metabolizing enzymes (CYP27A1, CYP27B1) and high expression of β-defensin-2; healing lesions reached higher levels of antimicrobial peptides than healthy skin treated with NB-UVB. It's the light that restructures the tissue. The capsule only raised a blood count that isn't diagnostic of anything.

SKIN HEALTH: EXOGENOUS VITAMIN D VS PHOTOMEDICINE

THE STUDY THEY DON'T QUOTE: THE COMBINATION IS TESTED — AND IT'S NEGATIVE

Those who support "synergy" cite Ala-Houhala and leave it at that. The problem is that the real question—does the combination work better than light alone?—has actually been tested. Twice, in the same year, with the wrong molecule for the convenient theories: the ACTIVE one.

Prystowsky JH, Knobler EH, Muzio PJ: “Oral calcitriol (1,25-dihydroxyvitamin D3) does not augment UVB phototherapy for plaque psoriasis” . J Am Acad Dermatol 1996;35(2 Pt 1):272-274. PMID 8708038. Note the subject: ORAL calcitriol — the active form, 1,25(OH)2D3, which cholecalciferol should become after the liver and kidneys. Not the over-the-counter precursor: the already active molecule, more powerful than the commercially available pill, no less. The result is in the title, unambiguously: it does not enhance UVB phototherapy in plaque psoriasis. If the active molecule adds nothing, the precursor molecule certainly adds nothing more.

And here's the second paper from the same group, in the same year: 16 randomized patients, placebo group, eight weeks: "Although calcitriol had no additive effect on phototherapy as a treatment modality" —textual: calcitriol had no additive effect on phototherapy as a treatment modality (Prystowsky JH, Muzio PJ, Sevran S, Clemens TL, J Am Acad Dermatol 1996;35(5 Pt 1):690-695, PMID 8912562). With a control group, this time: experimental arithmetic speaks for itself.

And these studies aren't obscure preprints: Prystowsky is cited in the dermatological canon. He appears as a reference in the official AAD–NPF guidelines (Elmets CA et al., J Am Acad Dermatol 2021;84(2):432-470, PMID 32738429)—which, in the section dedicated to vitamin D as a supplement, write in black and white: “While topical vitamin D analogues have benefit in psoriasis, oral supplementation does not directly improve disease activity at dosages that avoid hypercalcemia and calciuria. Therefore, oral vitamin D supplementation is not recommended for the treatment of psoriasis .” Translation: while TOPICAL vitamin D analogues are beneficial in psoriasis, oral supplementation does not directly improve disease activity at dosages that avoid hypercalcemia and calciuria. For this reason, oral vitamin D supplementation is not recommended for the treatment of psoriasis.

The false ancestor comes to the test and fails. Not in my opinion, but rather due to experimental arithmetic and the official position of American dermatology.

THE DISTINCTION THAT MAKES THE SPEECH CLEAN

Complete honesty, then, because the distinction makes them unassailable. Oral calcitriol as monotherapy for psoriasis has its own historical literature, in controlled doses: it is an active hormone-based drug, with a risk of hypercalcemia, administered by a doctor who measures calcium levels. It has nothing to do with the "sun plus supplement" idea—it's clinical endocrinology, not lifestyle.

And what does it actually do with light, in documented dermatological practice? TOPICAL vitamin D analogues—calcipotriol spread on the plaque—along with phototherapy. A local, not a systemic, approach: a drug applied where needed, with local action, two pharmacokinetics, two literatures. If someone responds by citing topical analogues, they're conflating the spread drug with the ingested capsule: two completely different approaches. The guidelines themselves make this distinction—topical benefits, no recommendation for oral administration.

THE ANATOMY OF THE FALSE ANCESTRAL

Now the promise of the title can be kept: the complete anatomy.

The "false ancestral" is a protocol passed off as ancient wisdom, containing a molecule no ancestor has ever seen, produced by a process no ancestor could even have described: sheep shearing, raw lanolin, saponification, cholesterol extraction, chemical conversion to 7-dehydrocholesterol, artificial ultraviolet irradiation in the factory, purification. Calling this supply chain "ancestral" is drop-shipping concepts: you're not returning to nature—you're packaging ancient concepts around an industrial product and shipping them.

You know the rest of the story: the drop-shipping, the tax office across the border, the "CE" (which stands for China Export) on certain products, the after-sales service that doesn't answer the phone. It's the usual story, already told on this blog: I'll touch on it and move on, because here the science is more than enough.

And science says this: psoriasis was the only area where the fake ancestor had brought a study to light. The study measures the pill in the blood. The real combination, tested with the active molecule, adds nothing. Official dermatology does not recommend oral supplementation. The compromise hasn't found the experiment to support it—because it's not a protocol: it's a tactic to avoid displeasing anyone and to try to sell to everyone.

THE APOLLO METHOD: THE ANCESTRAL FAKE IN A 10.000 IU PER DAY VERSION

While we're still working on this, let's also take a look at the "Apollo Method" for psoriasis: 10.000 IU of cholecalciferol per day, a Paleo diet with rice, which Paleo didn't include, and the rationale that rice helps "reduce adrenal stress . " I'M INTIMATELY INTENDED TO SAY: SURREAL! Let's dismantle it in three steps, because it's a maximalist version of the false ancestral diet: first the minimum dose listed on the label, now the opposite leap.

First move: the part that works isn't the pill. I'll grant you the anti-inflammatory dietary strategy: a diet based on real foods, without processed products, acts on the inflammatory process by itself. But here's the thing: when the patient improves, the credit goes to the entire protocol, including the capsule. The diet is the statistical Trojan horse of the method: it pays for the results, which end up in the vitamin D account.

The Paleolithic diet is inversely associated with all causes of death.

Second move: 10.000 IU is not nutrition, it's over-the-counter pharmacology. The numbers, verified: the recommended requirement is 600–800 IU per day (IOM 2011); the tolerable upper limit—the safety ceiling beyond which chronic intake is no longer considered safe—is 4.000 IU (IOM 2011; EFSA 2023). Ten thousand IU is 12–16 times the requirement and two and a half times the tolerable upper limit . Remember what the AAD–NPF guidelines cited above write: oral supplementation does not improve disease activity “at dosages that avoid hypercalcemia and calciuria .” The corollary is embarrassing for the method: to see an effect on plaque, you have to enter the territory where the molecule acts as an IMMUNOSUPPRESSIVE HORMONE, making people shout for a miracle , not as a nutrient.

And the effect is there, and that's exactly what I say: temporary immunosuppression. Psoriasis is a disease of the Th17 axis, and active vitamin D modulates the activity of human Th17 lymphocytes (He Y et al., RMD Open 2025;11(3):e005547, PMID 40973226). Oral calcitriol—the active, drug-like molecule—reduces the PASI from 18,4 to 7,8 in 24 months, with calciuria rising by 148%, monitored by the doctor, because it is a drug and behaves like a drug (Perez A et al., Br J Dermatol 1996;134(6):1070-1078, PMID 8763427). The Apollo Method did not discover a therapy: it replicated a hormonal protocol from the 1990s. The plaques clear away as long as the immunosuppressive hormone keeps coming in — and that's not healing, it's turning off the alarm and taking out the batteries.

Third move, the funniest one: laughter for "adrenal stress." This is where the method plays its trump card—and that trump card has a grain of biochemical truth that I've explained in detail in the video:

High-glycemic index rice before bed really does shorten the time it takes to fall asleep: Twelve healthy men consumed jasmine rice (GI 109) versus mahatma rice (GI 50) four hours before bedtime—sleep onset latency decreased from 17,5 ± 6,2 to 9,0 ± 6,2 minutes, P = 0,009 (Afaghi A, O'Connor H, Chow CM, Am J Clin Nutr 2007;85(2):426-430, PMID 17284739). The mechanism: Carbohydrates raise plasma tryptophan, a precursor to serotonin. So yes: the patient sleeps better, feels less tense, and attributes it all to the method. But evening laughter is a dietary tranquilizer—temporary, measured, and identical in every way to the spaghetti aglio e olio midnight that we'll be using the next time a biochemist with an honors degree explains to us that carbohydrates help us sleep.

What remains of the Apollo Method, dismantled? An anti-inflammatory diet that works on its own, a pharmacologically effective immunosuppressant hormone that only works when taken at high doses, and a bowl of rice that promotes sleep. Three separate effects, no proven synergy, and the diet's merit given to the capsule— while the documented therapy for psoriasis, as we saw above, remains the light.

And today, with the arrival of HALLEY in our warehouses, we have it for all budgets!

Halley – Multispectrum Lamp for Photobiomodulation and UVB-NB Treatment

 

WHERE WE ARE SIMPLIFYING

Honesty of method, as always. The study cited by proponents of synergy is small—12 patients—and without a control group: its limitation is also its doom, because that design cannot demonstrate synergies, only blood variations. The negative study dates back to 1996: the literature is dated because after that response, no one saw fit to refinance the question—and this, in itself, is a fact. Psoriasis is a chronic autoimmune disease: phototherapy is a medical therapy with dosimetry, skin type, and dermatological follow-up, not improvised sun exposure; those with the disease see a dermatologist, and supplementation is discussed with their doctor. Finally, serum 25(OH)D measures circulating reserves, not local hormonal activity in tissues—a topic already discussed here:

VITAMIN D (CHOLECALCIFEROL) IS A DRUG AND NOT A SUPPLEMENT

CLOSURE: THE SUN REMAINS THE PRIMARY LIGHT

Let me clarify, as always: none of this is anti-solar. The sun remains the primary light (true ancestral light). Always. This blog's method is light training—conscious exposure, the right times, morning light, progression that respects your skin type—and it stays exactly where it was.

Psoriasis simply served as a testing ground, and the verdict was reached: the light does the clinical work, the pill is measured in the blood. And whoever sells the compromise doesn't have a thesis: they have a business plan.

This article is the result of a collaboration between Angelo Rossiello and an advanced artificial intelligence. The scientific study and other references were provided by Angelo, who gave precise guidance on structure, tone, and objectives. The AI ​​developed the draft, while Angelo reviewed and validated each scientific statement using a method he calls a "refinement loop."

References (verified on PubMed on 09/14/2026):

1. Ala-Houhala MJ, Karppinen T, Vähävihu K, Kautiainen H, Dombrowski Y, Snellman E, Schauber J, Reunala T. Narrow-band ultraviolet B treatment boosts serum 25-hydroxyvitamin D in patients with psoriasis on oral vitamin D supplementation. Acta Derm Venereol. 2014;94(2):146-151. PMID 23995795. DOI 10.2340/00015555-1685.
2. Prystowsky JH, Knobler EH, Muzio PJ. Oral calcitriol (1,25-dihydroxyvitamin D3) does not augment UVB phototherapy for plaque psoriasis. J Am Acad Dermatol. 1996;35(2 Pt 1):272-274. PMID 8708038. DOI 10.1016/s0190-9622(96)90352-7.
3. Prystowsky JH, Muzio PJ, Sevran S, Clemens TL. Effect of UVB phototherapy and oral calcitriol (1,25-dihydroxyvitamin D3) on vitamin D photosynthesis in patients with psoriasis. J Am Acad Dermatol. 1996;35(5 Pt 1):690-695. PMID 8912562. DOI 10.1016/s0190-9622(96)90722-7.
4. Elmets CA, Lim HW, Stoff B, et al. Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with phototherapy. J Am Acad Dermatol. 2019;81(3):775-804. PMID 31351884. DOI 10.1016/j.jaad.2019.04.042.
5. Elmets CA, Korman NJ, Prater EF, et al. Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures. J Am Acad Dermatol. 2021;84(2):432-470. PMID 32738429. DOI 10.1016/j.jaad.2020.07.087.
6. He Y, Van Heeswijk B, Mus AMC, Davelaar N, Bisoendial R, Lubberts E. Active vitamin D acts in vitro as an adjuvant to anti-TNFα treatment in a psoriatic synovial fibroblast activation model by modulating human Th17 activity. RMD Open. 2025;11(3):e005547. PMID 40973226. DOI 10.1136/rmdopen-2025-005547.
7. Perez A, Raab R, Chen TC, Turner A, Holick MF. Safety and efficacy of oral calcitriol (1,25-dihydroxyvitamin D3) for the treatment of psoriasis. Br J Dermatol. 1996;134(6):1070-1078. PMID 8763427.
8. Afaghi A, O'Connor H, Chow CM. High-glycemic-index carbohydrate meals shorten sleep onset. Am J Clin Nutr. 2007;85(2):426-430. PMID 17284739. DOI 10.1093/ajcn/85.2.426.
9. Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. The National Academies Press, 2011 (RDA 600–800 IU/day; UL 4.000 IU/day); EFSA, Tolerable upper intake level for vitamin D, 2023 (100 µg/day).
10. Whalen KA, Judd S, McCullough ML, et al. J Nutr. 2017;147(4):612-620. PMID 28179490. DOI 10.3945/jn.116.241919.

Disclaimer: The information in this article is for informational purposes only and is not a substitute for medical advice. Do not discontinue or change any treatments without consulting your doctor.

FACT CHECK — “THE FALSE ANCESTRAL IS TESTED BY PSORIASIS” (September 15, 2026)

MY MISTAKE — “BEYOND” IN THE ITALIAN LYRICS

In the Apollo Method section, second move:

“the upper tolerable limit — the safety ceiling beyond which chronic intake is no longer considered safe — is 4.000 IU”

It's my fault: an English word slipped into my draft. Fix: replace "beyond" with "oltre."

The Paleolithic Diet Claim — True Source, Incorrect Statement

The image caption in the Apollo Method section says:

“The Paleolithic diet is inversely associated with all causes of death.”

The source exists and I just checked it: Whalen KA et al., “Paleolithic and Mediterranean Diet Pattern Scores Are Inversely Associated with All-Cause and Cause-Specific Mortality in Adults”, J Nutr 2017;147(4):612-620, PMID 28179490, DOI 10.3945/jn.116.241919 — REGARDS cohort, 21.423 adults, 2.513 deaths, median follow-up 6,25 years. Real data.

But as written, the phrase says the opposite of what it means: "associated with all causes of death" read literally sounds like diet is associated with causes of death . The correct concept is "all-cause mortality." Recommended fix:

“The Paleolithic diet is associated with lower all-cause mortality.”

And if you want to lock it down, add the reference at the end as number 10: Whalen KA, Judd S, McCullough ML, et al. J Nutr. 2017;147(4):612–620. PMID 28179490. DOI 10.3945/jn.116.241919. — so the claim in the image also has its primary source.

“IN INCREASING DOSES” — ADDITION WITHOUT SOURCE

At the end of the Apollo Method section: "a pharmacologically dosed immunosuppressant hormone that works as long as you take it at increasing doses ." Dose escalation isn't mentioned in any of the sources cited (Perez uses fixed doses adjusted by the doctor, not increasing doses). This is yet another statement a critic can attack. Fix: remove "at increasing doses"—the sentence is stronger without it, because the already documented truth is brutal: it works as long as you take it , period.

TWO TYPES IN YOUR ADDITIONS (paragraph “quacks”)

• “because this is sensational” → because
• “Yes, of course, TO TAKE HOME!” → Yes, Certain

FOUR TECHNICAL ARRANGEMENTS

1. EMPTY ALT images — HTML checked: all images in the article (the ancestral capsule, also used on the cover, the sun/capsule, the blood/skin, and the “gatekeeping” stock image) have empty ALT attributes. Yoast will flag them all. Texts ready:
   • Sun vs. Capsule: "Fake Ancient Natural Sun vs. Industrial Capsule Supplementation"
   • Blood/Skin: "Fake ancestral NB-UVB phototherapy marker in the blood is not healed skin"
   • Cave Capsule: "Fake ancestral cholecalciferol capsule among cave paintings, industrial molecule"
   • If you hold the stock “gatekeeping”: “fake ancestral gatekeeping of the electricity market”
2. Date of referencesThe list says "verified on PubMed on 09/14/2026," but I verified references 06-08 (He, Perez, Afaghi) this morning, on 09/15. I suggest "09/14 and 15/2026"—or no one will notice, but if someone opens them and compares the access dates, they'll blame the method.
3. Optional precision on the citation He: the paper is vitro, on a model of psoriatic synovial fibroblasts. As written, it is already correct (“modulates the activity of human Th17 lymphocytes” — that's the title of the paper), but if you want maximum precision: “(He Y et al., RMD Open 2025;11(3):e005547, PMID 40973226 — on cell cultures)”. Your choice.
4. SEO Note: the published H1 title has changed from the confirmed one (“THE PILL IS ONLY THE MEASURE” instead of “IT CAN BE MEASURED”) — it's your choice and it works, the meta title and meta description remain consistent with the keyword “fake ancestral”. Just one thing: with the keyword in the H1, Yoast stays green. Nothing can be done.

EVERYTHING ELSE VERIFIED ✓